JPS5572115A - Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide - Google Patents
Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxideInfo
- Publication number
- JPS5572115A JPS5572115A JP10582079A JP10582079A JPS5572115A JP S5572115 A JPS5572115 A JP S5572115A JP 10582079 A JP10582079 A JP 10582079A JP 10582079 A JP10582079 A JP 10582079A JP S5572115 A JPS5572115 A JP S5572115A
- Authority
- JP
- Japan
- Prior art keywords
- 11dioxide
- antibacterial activity
- strengthening agent
- agent made
- penicillanic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80432077A | 1977-06-07 | 1977-06-07 | |
| US87938178A | 1978-02-21 | 1978-02-21 | |
| US89045178A | 1978-03-29 | 1978-03-29 | |
| US96376378A | 1978-11-27 | 1978-11-27 | |
| US06/017,807 US4276285A (en) | 1977-06-07 | 1979-03-05 | Combinations of penicillanic acid 1,1-dioxide with 7-(D-2-[4-ethylpiperazin-2,3-dione-1-carboxamido]-2-[4-hydroxyphenyl]acetamido)-3-([1-methyl-5-tetrazolyl]thiomethyl)-3-desacetoxymethylcephalosporanic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5572115A true JPS5572115A (en) | 1980-05-30 |
Family
ID=27533756
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53068726A Expired JPS6056160B2 (ja) | 1977-06-07 | 1978-06-07 | β−ラクタマ−ゼ阻害剤としてのペニシラン酸1,1−ジオキシド |
| JP10582079A Pending JPS5572115A (en) | 1977-06-07 | 1979-08-20 | Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53068726A Expired JPS6056160B2 (ja) | 1977-06-07 | 1978-06-07 | β−ラクタマ−ゼ阻害剤としてのペニシラン酸1,1−ジオキシド |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4276285A (ja) |
| JP (2) | JPS6056160B2 (ja) |
| AU (2) | AU514926B2 (ja) |
| BE (1) | BE877542R (ja) |
| MX (1) | MX9203747A (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57146784A (en) * | 1981-02-02 | 1982-09-10 | Pfizer | Slightly water-soluble salt of penicillanic acid 1,1-dioxide |
| JPS58216191A (ja) * | 1982-05-24 | 1983-12-15 | フアイザ−・インコ−ポレ−テツド | ペニシラン酸ジオキサイド前駆薬 |
| JPS59104319A (ja) * | 1982-12-06 | 1984-06-16 | Chugai Pharmaceut Co Ltd | 抗菌剤およびそのキツト |
| JPH02104528A (ja) * | 1988-07-08 | 1990-04-17 | Young S Kim | 抗菌用組成物 |
| JPH06234640A (ja) * | 1993-01-12 | 1994-08-23 | Suu Kim Yon | β−ラクタマーゼ耐性抗生物質の組成物 |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5661386A (en) * | 1979-10-11 | 1981-05-26 | Leo Pharm Prod Ltd | Manufacture of penicillanic acid derivative |
| US4361513A (en) * | 1980-12-11 | 1982-11-30 | Pfizer Inc. | Esters of penicillanic acid sulfone |
| US4419284A (en) * | 1981-03-23 | 1983-12-06 | Pfizer Inc. | Preparation of halomethyl esters (and related esters) of penicillanic acid 1,1-dioxide |
| US4351840A (en) * | 1981-09-18 | 1982-09-28 | Pfizer Inc. | Antibacterial esters of resorcinol with ampicillin and penicillanic acid 1,1-dioxide derivatives |
| US4406887A (en) * | 1981-10-13 | 1983-09-27 | Bristol-Myers Company | Method for treating resistant bacteria including anaerobes |
| AT392903B (de) * | 1987-10-08 | 1991-07-10 | Hoechst Ag | Pharmazeutische zubereitung enthaltend ein cephalosporin und ein penemantibiotikum |
| JP3236261B2 (ja) * | 1998-04-09 | 2001-12-10 | 大塚化学株式会社 | ハロゲン化β−ラクタム化合物の製造法 |
| CN102952147B (zh) * | 2011-08-16 | 2015-04-08 | 台州市信友医药化工有限公司 | 一种舒巴坦酸的合成方法 |
| CN102702228A (zh) * | 2012-06-26 | 2012-10-03 | 齐鲁天和惠世制药有限公司 | 一种舒巴坦制备方法 |
| CN106699774A (zh) * | 2016-12-30 | 2017-05-24 | 淄博鑫泉医药技术服务有限公司 | 舒巴坦钠的制备方法 |
| KR102668212B1 (ko) * | 2018-09-28 | 2024-05-23 | 삼성전자 주식회사 | 자동 초점 방법 및 이를 수행하는 전자 장치 |
| CN111848645B (zh) * | 2020-07-20 | 2024-03-08 | 青岛科技大学 | 一种制备舒巴坦酸的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3197466A (en) * | 1961-10-30 | 1965-07-27 | Smith Kline French Lab | Penicillin sulfoxides and process |
| BE648188A (ja) * | 1963-05-29 | 1964-09-16 | ||
| US3536698A (en) * | 1968-02-27 | 1970-10-27 | Lilly Co Eli | Simplified method for esterification of antibiotics via carbonate anhydride intermediates |
-
1978
- 1978-06-07 JP JP53068726A patent/JPS6056160B2/ja not_active Expired
-
1979
- 1979-03-05 US US06/017,807 patent/US4276285A/en not_active Expired - Lifetime
- 1979-06-27 AU AU48465/79A patent/AU514926B2/en not_active Ceased
- 1979-07-06 BE BE0/196180A patent/BE877542R/fr not_active IP Right Cessation
- 1979-08-20 JP JP10582079A patent/JPS5572115A/ja active Pending
-
1980
- 1980-10-31 AU AU64030/80A patent/AU522487B2/en not_active Ceased
-
1992
- 1992-06-29 MX MX9203747A patent/MX9203747A/es unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57146784A (en) * | 1981-02-02 | 1982-09-10 | Pfizer | Slightly water-soluble salt of penicillanic acid 1,1-dioxide |
| JPS58216191A (ja) * | 1982-05-24 | 1983-12-15 | フアイザ−・インコ−ポレ−テツド | ペニシラン酸ジオキサイド前駆薬 |
| JPS59104319A (ja) * | 1982-12-06 | 1984-06-16 | Chugai Pharmaceut Co Ltd | 抗菌剤およびそのキツト |
| JPH02104528A (ja) * | 1988-07-08 | 1990-04-17 | Young S Kim | 抗菌用組成物 |
| JPH06234640A (ja) * | 1993-01-12 | 1994-08-23 | Suu Kim Yon | β−ラクタマーゼ耐性抗生物質の組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6056160B2 (ja) | 1985-12-09 |
| AU6403080A (en) | 1981-03-12 |
| BE877542R (fr) | 1980-01-07 |
| US4276285A (en) | 1981-06-30 |
| AU4846579A (en) | 1980-05-29 |
| AU522487B2 (en) | 1982-06-10 |
| AU514926B2 (en) | 1981-03-05 |
| JPS543094A (en) | 1979-01-11 |
| MX9203747A (es) | 1992-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH15706A (en) | Esters of penicillanic acid 1,1-dioxide | |
| JPS5572115A (en) | Antibacterial activity strengthening agent made of penicillanic acid 1*11dioxide | |
| NZ187476A (en) | Penicillanic acid 1,1-dioxides pharmaceutical compositions and intermediate 1-oxides | |
| JPS54160317A (en) | Manufacture of dimethylaminomethylene bisphosphoric acid | |
| ZA792004B (en) | Novel compounds of sterilizing activity | |
| JPS543058A (en) | Production of ascorbic acid | |
| JPS5463026A (en) | Nncarboxyalkaneeaminoalkaneepolyphosphoric acid* its alkali salt and manufacture | |
| JPS5419913A (en) | Alphaahalomethyl derivative of alphaaamino acid | |
| JPS55154977A (en) | Penicillanic acid derivative* its manufacture and use | |
| JPS5430160A (en) | Novel indoleacetoxyacetylamino acid compound * production thereof and medical use | |
| JPS5414916A (en) | Alphaaacetylene derivative of alphaaamino acid | |
| GB2022073B (en) | Derivatives of 5-nitro-imidazole with anti-protozoic activity | |
| GB2002347B (en) | Derivatives of amidino penicillanic acid | |
| JPS5419944A (en) | Production of antiitumor agent | |
| JPS5495573A (en) | Manufacture of 3*44methylene dioxymandelic acid | |
| NZ187327A (en) | Preparation of 6-(-)-alpha-amino-para-hydroxy phenylacetamido) penicillanic acid (amoxycillin) | |
| GB2002764B (en) | Derivatives of n-substituted-2-aminobenzoic acid | |
| JPS55120588A (en) | Penicillanic acid 1*11dioxide and manufacture and intermediate of same | |
| JPS5448749A (en) | Manufacture of 11aminoo44bromoanthraquinonee22sulfonic acid | |
| JPS53136531A (en) | Production of antiisweat agent | |
| JPS5359694A (en) | Production of sstriazoloo *1*55a**pyridinee22yll5*77 dimethyllphosphoric acid derivative and harmful organism combaiting agent containing same | |
| EG13473A (en) | Derivatives of oxanilic acid | |
| JPS5452008A (en) | Manufacture of substituted urea | |
| JPS5392744A (en) | Derivative of omegaaaryloxyy133 prostin acid | |
| GB2006255B (en) | Aqueous solutions of cleaning agents |